Progyny logo

Progyny

PGNY | NASDAQ
Chart Builder DCF Calculator
$37.15
+$0.97 (+2.68%)
At close: Nov 16, 2026, 4:00 PM ET
$37.15
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:56 PM ET
+2.68%

Rating

Updated: Nov 16, 2026
64.6
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #98/1021 (Top 10%)

Key Statistics

Market Data

Market Cap $2.74B
1D Range
36.27 37.20
52W Range
16.30 37.20

Valuation (TTM)

PE 34.08
PB 6.61
EV/EBITDA 18.25

Valuation (NTM)

Forward PE 27.41
Forward PEG 0.32
Price Target $36.00
Loading financial charts...

Profile

Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United Stat...

Sector Healthcare
Employees 846
IPO Date Oct 25, 2019
Fiscal Year January - December

Latest News

Progyny (PGNY) Is Up 3.85% in One Week: What You Should Know

15 hours ago · zacks.com

Progyny (PGNY) Is Up 3.85% in One Week: What You Should Know
Progyny: 3 Key Takeaways for Long-Term Investors

6 days ago · fool.com

Progyny: 3 Key Takeaways for Long-Term Investors
Progyny Q3 Earnings Call Highlights

12 days ago · marketbeat.com

Progyny Q3 Earnings Call Highlights
Progyny, Inc. (PGNY) Q3 2026 Earnings Call Transcript

12 days ago · seekingalpha.com

Progyny, Inc. (PGNY) Q3 2026 Earnings Call Transcript
Progyny (PGNY) Tops Q3 Earnings and Revenue Estimates

12 days ago · zacks.com

Progyny (PGNY) Tops Q3 Earnings and Revenue Estimates
Progyny, Inc. Announces Third Quarter 2026 Results

13 days ago · globenewswire.com

Progyny, Inc. Announces Third Quarter 2026 Results
New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits

20 days ago · globenewswire.com

New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits
New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model

22 days ago · globenewswire.com

New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model
Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report

27 days ago · globenewswire.com

Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report
Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting

1 month ago · globenewswire.com

Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting

Earnings

Latest Earnings
Nov 4, 2026
EPS
$0.52
Beat +66.13%
REV
$341.25M
Beat +0.14%
Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
11
Consensus
Buy
Price Target
$36.00
Downside
-3.10%
Buy (9)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.